Viewing Study NCT06350734



Ignite Creation Date: 2024-05-06 @ 8:22 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06350734
Status: RECRUITING
Last Update Posted: 2024-04-05
First Post: 2024-04-02

Brief Title: Quality of Life After Treatment for Bladder Cancer The Bladder Cancer Survivorship Study
Sponsor: Mayo Clinic
Organization: Mayo Clinic

Study Overview

Official Title: Quality of Life After Treatment for Bladder Cancer The Bladder Cancer Survivorship Study
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study evaluates the effect of bladder cancer treatment on quality of life
Detailed Description: PRIMARY OBJECTIVES

I To compare general and disease-specific quality of life outcomes at 6 12 24 and 36 months after treatment for localized bladder cancer using the PROMIS-29 and the Bladder Cancer Index BCI respectively

II To identify patient level characteristics that may influence quality of life outcomes after treatment for localized bladder cancer

OUTLINE This is an observational study

Patients complete surveys and also have their medical records reviewed on study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
NCI-2024-00973 REGISTRY None None
18-004675 OTHER Mayo Clinic Institutional Review Board None